Evidence map›Paper›PMID 42666016›Full record

ArticleJournal of cachexia, sarcopenia and muscle2026

Musculoskeletal (Mal)adaptations in Response to a > 30 000-km Running Challenge.

Tomas Venckunas, Thomas Chaillou, Leonardo Cesanelli, Danguole Satkunskiene, Saulius Rutkauskas, Audrius Snieckus, Petras Minderis, Darja Nikitina, Jurgita Skieceviciene, Juozas Kupcinskas and 7 more

Abstract readCase Reports
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tomas VenckunasInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.ORCID https://orcid.org/0000-0002-1956-6616
Thomas ChaillouSchool of Health Sciences, Örebro University, Örebro, Sweden.ORCID https://orcid.org/0000-0002-5322-4150
Leonardo CesanelliInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.ORCID https://orcid.org/0000-0003-2822-1836
Danguole SatkunskieneInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.ORCID https://orcid.org/0000-0002-2008-6150
Saulius RutkauskasDepartment of Radiology, Lithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania.
Audrius SnieckusInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.
Petras MinderisInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.ORCID https://orcid.org/0000-0001-9522-6050
Darja NikitinaInstitute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.ORCID https://orcid.org/0000-0002-9942-5118
Jurgita SkiecevicieneInstitute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Juozas KupcinskasInstitute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Lorenz WebersbergerSchool of Health Sciences, Örebro University, Örebro, Sweden.ORCID https://orcid.org/0009-0008-3966-2091
Johanna T LannerDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-1222-9473
Mantas MickeviciusInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.ORCID https://orcid.org/0000-0002-2557-5471
Birutė GumauskieneDepartment of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Asta KuzmickaiteSporto Klinika, Kaunas, Lithuania.
Andrejus SubociusInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.
Sigitas KamandulisInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUltra-endurance sports are increasingly popular, yet the long-term physiological consequences of sustained extreme training loads remain poorly understood. In particular, the effects of prolonged ultra-endurance exercise on skeletal muscle structure, function and molecular remodelling are largely unknown. This case study examined a highly experienced ultra-endurance athlete who completed a world-record attempt to run 30 300 km, with extensive phenotyping focusing on skeletal muscle adaptations and recovery.

methodsA 49-year-old male athlete (172 cm, 65 kg) ran ~70 km daily for 15 months. Musculoskeletal, cardiac and visceral ultrasonography, leg muscle strength and power measurements were performed before and after the challenge. Muscle biopsies (n = 4) from vastus lateralis were obtained immediately after completion and during 17 months of recovery to assess myosin heavy chain (MHC) composition, mitochondrial electron transport chain (ETC) complexes and proteins involved in mitochondrial turnover, autophagy and inflammation. Body composition, haematological and biochemical markers, and gut microbiota composition were monitored longitudinally.

resultsThe athlete ran 30 300 km over 444 days, maintaining a daily distance of ~70 km despite substantial musculoskeletal discomfort, including a tibial stress reaction mid-challenge, which resolved gradually with continued running. Body mass decreased by ~3 kg, primarily reflecting fat loss (~83%), accompanied by reductions in muscle thickness, maximal strength and power. Circulating creatine kinase (3-15-fold), oxidative stress markers (~50%) and GDF8 (~10%-50%) were sustainedly increased, whereas IGF-I decreased (~10%-40%), suggesting a reduced anabolic environment during the challenge. Muscle biopsy analyses revealed a progressive recovery of mitochondrial function during the 17 months following the challenge, as evidenced by a progressive increase in ETC protein abundance and the expression of regulators of mitochondrial dynamics and quality control (MFN2, PARKIN, DRP1). In contrast, markers of autophagy, apoptosis and inflammation were decreased during the 17-months post-challenge (LC3A/B-I by ~50%, CASP3 by ~60% and NF-κB

conclusionsSustaining daily ultrarunning for more than 1 year induces substantial skeletal muscle remodelling, including reduced muscle size, impaired contractile function and mitochondrial maladaptations, despite largely preserved endocrine and haematological stability. These findings highlight skeletal muscle as a primary physiological system challenged during extreme endurance exercise and demonstrate that recovery from such perturbations may require more than one year.

Indexed as

Adaptation, PhysiologicalMuscle, SkeletalRunningAthletesBiomarkersBody CompositionHumansMaleMiddle AgedMuscle StrengthPhysical EndurancePost-Exercise RecoveryBiomarkersgut microbiotaMHC compositionmitochondrial functionmuscle wastingskeletal muscleultra‐endurance

Identifiers

PMID42666016
PMCPMC13525328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.